ResearchMoz

La Merie Publishing Market Research Reports

La Merie Publishing is an independent business information provider for the biopharmaceutical industry. We publish reports and newsletters, and provide the service of preparing tailor-made reports. The full range of our products are commercialized via our associated biotech portal PipelineReview.com and reselling partners.

List of reports from La Merie Publishing

Displaying 1 to 30 (of 31 records)
Peptide Therapeutics Pipeline Database: 1-Year Subscription
Nov 2014  
Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files. Each project (file) is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of...
$1016
Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders
Jul 2014  
This business report from July 2014 is based on the identification, description and assessment of all relevant stakeholders in the field of botulinum neurotoxins. The report analyzes the existing product portfolios in regulated and less regulated markets, commercial information, and measures to maintain sales and market shares by upside indications and life cycle management measures. The...
$2656
Competitor Analysis: Cancer Vaccines
Mar 2014  
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail...
$1112
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014
Mar 2014  
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of March 2014. Marketed...
$1523
Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis
Jan 2014  
The report entitled „Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis“ published in January 2014 is based on the evaluation of more than 90 companies. The report analyzes established and new antibody-drug conjugate (ADC) technologies, business activities and opportunities and assesses more than 100 ADC development and research programs. The...
$2873
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
Oct 2013  
A  comparative analysis and assessment of TCR technologies, pipelines and  companies from an industry perspective Therapeutic monoclonal antibodies have become an  increasingly successful treatment modality with sales of US$ 65 bln in the year  2012 and with an average (continuous) annual growth rate from 2006 to 2012 of  18.9%. While antibody technologies...
$1919
Protein Target & Pipeline Database: 1-Year Subscription
Jul 2013  
Product description Subscription to La Merie Publishing’s proprietary Protein Database provides online access to information about more than 1900 project entries for therapeutic proteins on the market and in research & development. Pre-established and free search functions allow to identify proteins according to their Target (e.g. Factor VIII, G-CSF, FSH)...
$1588
Competitor Analysis ErbB / Her Receptor Antagonists
Jul 2013  
The present Competitive Intelligence Report about antagonists of the ErbB/Her receptor pathway provides a competitor evaluation in the field of ErbB1 (EGF-R), ErbB2 (Her), ErbB3 (Her) and ErbB4 (Her4) receptor targeting molecules for treatment of cancer as of July 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since...
$853
Antibody Target, Technology & Pipeline Database: 1-Year Subscription
Jul 2013  
Subscription to La Merie Publishing’s proprietary Antibody Database provides online access to information about more than 2,400 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their Technology (e.g. antibody-drug conjugate, bispecific,...
$1705
Recombinant Coagulation Factors 2013 - The Race to Market and for Market Shares: A Technology & Pipeline Assessment and Corporate Benchmarking Analysis
Jun 2013  
A Technology & Pipeline Assessment and Corporate Benchmarking Analysis The report “Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares: Technology & Pipeline Assessment and Corporate Benchmarking Analysis” of June 2013 describes a market forecast based on growth of historical sales of recombinant coagulation factors. The report...
$2767
Competitive Information Service Package - 1-year subscription
May 2013  
Subscription to this product provides access during one year to three Competitive Intelligence information products released by La Merie Publishing with great cost savings: 1) Flat-Rate Access to La Merie Publishing Reports: Access during one year to all existing and new reports produced by La Merie Publishing and listed in the online store. Among La Merie Publishing...
$7871
Competitor Analysis: Coagulation Factors
May 2013  
Competitor Analysis: Coagulation Factors Product description The Competitive Intelligence Report Coagulation Factors provides a competitor analysis of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation disorders as of May 2013. Purchase of the pdf report includes a 6-month online...
$784
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
May 2013  
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and...
$2092
Competitor Analysis: Antibody-Drug Conjugates (ADC)
Apr 2013  
Product description The present Competitive Intelligence Report about Antibody-Drug Conjugates (ADC) / Immunoconjugates provides a competitor evaluation in the field of tumor targeting antibodies conjugated via a linker with a drug payload for treatment of cancer as of April 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the...
$785
Influence of Antibody Attributes on Clinical Success - A Technology and Coporate Benchmark Analysis
Mar 2013  
The analytical report „Influence of Antibody Attributes on Clinical Success – A Technology and Coporate Benchmark Analysis“ evaluates the impact of a number of antibody attributes on the success rate of antibodies in clinical development. Among the antibody attributes studied  in this investigation are antibody generation technology, animal species of the parental...
$1203
Antibody Technologies and Attrition Rates - an industry analysis 2013
Mar 2013  
The report “Antibody Technologies and Attrition Rates – an industry analysis 2013” is based on the identification of the antibody generation technologies of 504 naked antibodies in clinical or market stages. Information was retrieved from scientific and corporate publications as well as from patent and legal literature. The report provides descriptive statistics of the...
$2781
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
Dec 2012  
Toll-Like Receptor (TLR) Agonists & Antagonists Product description The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small molecules, proteins, DNA, RNA and vaccines targeting the toll-like receptors (TLR) for treatment or prevention of cancer, infectious...
$910
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012
Mar 2012  
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012 This report “ Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012 ” published in March 2012 provides a compilation of business, commercial, clinical and scientific information about GLP-1 receptor agonists. A comprehensive...
$2524
Competitor Analysis: Anti-Infective Antibodies
Nov 2011  
Competitor Analysis: Anti-Infective Antibodies Product description The present Competitive Intelligence Report about Anti-Infective Antibodies provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies and human plasma-derived immunoglobulins and hyperimmunes for post-exposure prophylaxis and treatment of infectious diseases as...
$1029
Coagulation Factors 2011. Who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis
Oct 2011  
Coagulation Factors 2011 who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis Product description The report Coagulation Factors 2011 who does meet the market needs?  A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis provides a description, evaluation and assessment of the recombinant...
$3087
Vaccine Pipeline Database: 1-Year Subscription
Oct 2011  
Vaccine Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area...
$1287
Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis
Sep 2011  
Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis Product description This report “Antibody-Drug Conjugates 2011 – real breakthrough still to come: A Technology, Stakeholder and R&D Pipeline Analysis” published in September 2011 provides the most complete compilation of...
$2524
Competitor Analysis: Targeted Therapy of Hepatitis C
Aug 2011  
The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the...
$772
RNA Therapeutics Pipeline Database: 1-Year Subscription
Mar 2011  
RNA Therapeutics Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary RNA Therapeutics Pipeline Database provides online access to RNA Therapeutics on the market and in research & development. RNA Therapeutics include the classes of antisense, aptamers, small interfering RNA (siRNA)/RNA interference (RNAi) or Locked Nucleic Acid (LNA)...
$772
Therapeutic Protein Pipeline Database: 1-Year Subscription
Feb 2011  
Subscription to La Merie’s proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic proteins is intuitive. Data sets...
$1544
Antibody Pipeline Database: 1-Year Subscription
Nov 2010  
Subscription to La Meries proprietary Antibody Pipeline Database provides online access to more than 1,600 project entries for therapeutic antibodies on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest...
$1544
R&D Drug Pipeline Database: 2-Months Subscription
Aug 2010  
R&D Drug Pipeline Database: 2-Months Subscription Product description Subscription to La Meries proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mechanism of Action, Product Category, Therapeutic Area, indication and R&D Phase. Use of the...
$2573
R&D Drug Pipeline Database: 1-Year Subscription
Aug 2010  
R&D Drug Pipeline Database: 1-Year Subscription Product description Subscription to La Meries proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mechanism of Action, Product Category, Therapeutic Area, indication and R&D Phase. Use of the...
$7719
Flat-Rate Subscription to La Merie Reports with 24/7 Online Access
Jun 2010  
Subscription to this product provides online access during one year to all reports published by La Merie and available in the online store during the subscription. Among La Merie reports are more than 100 Competitor Analysis reports as well as a growing number of Brief and Full Reports. La Merie reports are continuously updated and newly released. Reports can be searched for and...
$5146
Oncology Pipeline Database: 1-Year Subscription
May 2010  
Oncology Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase. Use of the R&D database of cancer drugs is intuitive. Data sets of interest...
$2316
 
Displaying 1 to 30 (of 31 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData